Price
85.56
-0.47%52W Range
Market Cap
₹171.56 Cr
Traded: ₹0.03 Cr (0.02%) 0.0x
Free Float: ₹45.16 Cr (0.06% of FF traded)
Volume · 60D trend
3.14 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | +19.0% | -- | -- | -- |
| Return | -- | +42.0% | -5.0% | -40.0% | -- | Decelerating |
| Sales | -- | -- | -- | -- | +25.0% | -- |
| Profit | -- | -- | -- | -- | +3.0% | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit Before Tax |
| Tax % |
| Net Profit |
| Exceptional Items |
| EPS (Rs) |
| Sales Growth (YoY) |
| Sales Growth (QoQ) |
| OP Growth (YoY) |
| OP Growth (QoQ) |
| Profit Growth (YoY) |
| EPS Growth (YoY) |
| EPS Growth (QoQ) |
| OP Margin |
| Net Margin |
| Material Cost % |
| Employee Cost % |
| P/S |
| P/E |
| P/B |
Exchange Filings
50Submitting Newspaper Advertisement relating to the Unaudited Quarterly Standalone Financial Results for the quarter ended on 30th June, 2026.
Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting ....
Financial Results for the quarter ended on 30-06-2026
Proceedings
Postal Ballot Results by remove e voting process and Scrutinizer''s Report.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve (a) The Unaudited Financial ....
Committee Composition approved in the Outcome of Board Meeting dated 10th July, 2026 shall be read as effective from 21st April, 2026, being the effective date of the Appointment and resignation ....
Revised announcement submit.
Pursuant to the resignation of Mrs. Nehaben Patel (DIN: 09263180) from the office of Non-Executive Independent Director of the Company, the Board of Directors, at its meeting held on 21st ....
Certificate under Regulation 74(5) of SEBI DP Regulation for the quarter ended on 30th June, 2026
Postal Ballot Notice dated 4th July, 2026 published in Western times English and Gujarati Newspaper.
Postal Ballot Notice
Regularization of appointment of Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Non Executive Independent Director of the Company, appointment of M/s. Bhagat & Associates, Chartered Accountants ....
Closure of Trading Window
Resignation and Appointment of Statutory Auditor
Appointment and Resignation of Statutory Auditors and Internal Auditors.
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circulars issued thereunder, we wish to ....
Newspaper Publication of Audited Financial Results for the Quarter/ Year ended on 31st March, 2026. Thanks
Audited Financial Results
Audited Results
Annual Secretarial Compliance for the financial year ended on 31-03-2026.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve (a) The Audited Financial ....
Non Applicability of Large Corporate Entity
Revised Intimation of Appointment of Additional Director in the capacity of Non Executive Independent Director.
Revised Resignation of Non Executive Independent Director.
Appointment of Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director (Non Executive Independent) of the Company in the meeting of the Board of Director of the company by passing ....
Resignation of Mrs. Nehaben Sachinbhai Patel (DIN: 09263180) vide her letter dated 21st April, 2026 tendered her resignation form the said position.
Resignation of Non Executive Independent Director
Certificate under Reg 74(5) of SEBI DP Regulations
Closure of Trading Window
Clarification on Price Movement.
The Exchange has sought clarification from Indo Us Bio-Tech Ltd on March 10, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Us Agriseeds Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Us Agriseeds Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo US Agriseeds Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo US Agriseeds Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo US Agriseeds Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Us Agriseeds Ltd
Newspaper Advertisement relating to Unaudited Quarterly Results for the quarter ended on 31st December, 2025
Financial Results
Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting ....
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve consider, approve and take ....
Certificate under Reg 74(5) of SEBI DP Reg. for the quarter ended on 31st Dec 2025.
Closure of Trading Window
Disclosure under regulation 30 of SEBI LODR regarding receipt of summon from ED.
Announcement under Regulation 30 of SEBI LODR
Newspaper Advertisement relating to Unaudited Quarterly and Half Yearly Standalone Financial Results for the Quarter and Half year ended on 30th Sept. 2025.
Unaudited Financial Results for the Quarter ended on 30-09-2025.
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-Audited Standalone ....
Newspaper Publication regarding Notice of Postal Ballot.